National Health (Weighted average disclosed price – October 2020 reduction day) Amendment Determination 2020 (PB 88 of 2020) (Cth)

PB 88 of 2020

National Health (Weighted average disclosed price – October 2020 reduction day) Amendment Determination 2020

National Health Act 1953

I, THEA CONNOLLY, Assistant Secretary, Pricing and PBS Policy Branch, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated:  9 September 2020

THEA CONNOLLY

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

1. Name of Instrument

(1)     This instrument is the National Health (Weighted average disclosed price – October 2020 reduction day) Amendment Determination 2020.

(2)     This instrument may also be cited as PB 88 of 2020.

1. Commencement

This instrument commences on the day after it is registered.

1. Amendments to PB 54 of 2020

Schedule 1 amends the National Health (Weighted average disclosed price – October 2020 reduction day) Determination 2020 (PB 54 of 2020).

Schedule 1     Amendments

[1]     Schedule 1

after:

77 Entecavir Tablet 1 mg (as monohydrate) Oral ENTECLUDE 117.91

omit:

78	Epirubicin	Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL	Injection/intravesical	Epirubicin ACT	25.49
79	Epirubicin	Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL	Injection/intravesical	Epirube	50.98
80	Epirubicin	Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL	Injection/intravesical	Epirubicin Accord	50.98
81	Epirubicin	Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL	Injection/intravesical	Epirubicin ACT	50.98
82	Epirubicin	Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL	Injection/intravesical	Epirube	12.75
83	Epirubicin	Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL	Injection/intravesical	Epirubicin ACT	12.75
84	Etoposide	Powder for I.V. infusion 1 g (as phosphate)	Injection	Etopophos	342.38
85	Etoposide	Solution for I.V. infusion 100 mg in 5 mL	Injection	Etoposide Ebewe	34.24
86	Etoposide	Solution for I.V. infusion 100 mg in 5 mL	Injection	Pfizer Australia Pty Ltd	34.24

[2]     Schedule 1

after:

228 Zoledronic acid Solution for I.V. infusion 4 mg (as monohydrate) in 100 mL Injection DBL Zoledronic Acid 72.79

omit:

229	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Aclasta	97.45
230	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Osteovan	97.45
231	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Ostira	97.45
232	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Zoledasta	97.45

substitute:

229	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Aclasta	97.47
230	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Osteovan	97.47
231	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Ostira	97.47
232	Zoledronic acid	Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL	Injection	Zoledasta	97.47

Schedule 2     Amendments

[3]     Schedule 2

after:

1,024 Enoxaparin Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe Injection Enoxaparin Winthrop 54.37

insert:

1,024A	Epirubicin	Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL	Injection/intravesical	Epirubicin ACT	25.49
1,024B	Epirubicin	Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL	Injection/intravesical	Epirube	50.98
1,024C	Epirubicin	Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL	Injection/intravesical	Epirubicin Accord	50.98
1,024D	Epirubicin	Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL	Injection/intravesical	Epirubicin ACT	50.98
1,024E	Epirubicin	Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL	Injection/intravesical	Epirube	12.75
1,024F	Epirubicin	Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL	Injection/intravesical	Epirubicin ACT	12.75

[4]     Schedule 2

after:

1,125 Etoposide Capsule 50 mg Oral Vepesid 391.11

insert:

1,125A	Etoposide	Powder for I.V. infusion 1 g (as phosphate)	Injection	Etopophos	342.38
1,125B	Etoposide	Solution for I.V. infusion 100 mg in 5 mL	Injection	Etoposide Ebewe	34.24
1,125C	Etoposide	Solution for I.V. infusion 100 mg in 5 mL	Injection	Pfizer Australia Pty Ltd	34.24

[5]    Schedule 2

after:

1,594 Imipramine Tablet containing imipramine hydrochloride 25 mg Oral Tofranil 25 7.11

insert:

1,594A Imipramine Tablet containing imipramine hydrochloride 25 mg USP Oral Imipramine (Leading) 19.00

[6]     Schedule 2

after:

1,902 Levodopa with carbidopa Tablet 250 mg-25 mg (USP) Oral Carbidopa and Levodopa Tablets, USP 44.63

insert:

1,902A	Levodopa with carbidopa and entacapone	Tablet 100 mg-25 mg (as monohydrate)-200 mg	Oral	Lecteva	110.74
1,902B	Levodopa with carbidopa and entacapone	Tablet 100 mg-25 mg (as monohydrate)-200 mg	Oral	Carlevent	110.74
1,902C	Levodopa with carbidopa and entacapone	Tablet 100 mg-25 mg (as monohydrate)-200 mg	Oral	Stalevo 100/25/200mg	110.74
1,902D	Levodopa with carbidopa and entacapone	Tablet 150 mg-37.5 mg (as monohydrate)-200 mg	Oral	Lecteva	121.22
1,902E	Levodopa with carbidopa and entacapone	Tablet 150 mg-37.5 mg (as monohydrate)-200 mg	Oral	Carlevent	121.22
1,902F	Levodopa with carbidopa and entacapone	Tablet 150 mg-37.5 mg (as monohydrate)-200 mg	Oral	Stalevo 150/37.5/200mg	121.22
1,902G	Levodopa with carbidopa and entacapone	Tablet 50 mg-12.5 mg (as monohydrate)-200 mg	Oral	Carlevent	100.26
1,902H	Levodopa with carbidopa and entacapone	Tablet 50 mg-12.5 mg (as monohydrate)-200 mg	Oral	Lecteva	100.26
1,902I	Levodopa with carbidopa and entacapone	Tablet 50 mg-12.5 mg (as monohydrate)-200 mg	Oral	Stalevo 50/12.5/200mg	100.26
1,902J	Levodopa with carbidopa and entacapone	Tablet 125 mg-31.25 mg (as monohydrate)-200 mg	Oral	Lecteva	114.94
1,902K	Levodopa with carbidopa and entacapone	Tablet 125 mg-31.25 mg (as monohydrate)-200 mg	Oral	Stalevo 125/31.25/200mg	114.94
1,902L	Levodopa with carbidopa and entacapone	Tablet 125 mg-31.25 mg (as monohydrate)-200 mg	Oral	Carlevent	114.94
1,902M	Levodopa with carbidopa and entacapone	Tablet 200 mg-50 mg (as monohydrate)-200 mg	Oral	Carlevent	130.86
1,902N	Levodopa with carbidopa and entacapone	Tablet 200 mg-50 mg (as monohydrate)-200 mg	Oral	Stalevo 200/50/200mg	130.86
1,902O	Levodopa with carbidopa and entacapone	Tablet 200 mg-50 mg (as monohydrate)-200 mg	Oral	Lecteva	130.86
1,902P	Levodopa with carbidopa and entacapone	Tablet 75 mg-18.75 mg (as monohydrate)-200 mg	Oral	Lecteva	104.87
1,902Q	Levodopa with carbidopa and entacapone	Tablet 75 mg-18.75 mg (as monohydrate)-200 mg	Oral	Carlevent	104.87
1,902R	Levodopa with carbidopa and entacapone	Tablet 75 mg-18.75 mg (as monohydrate)-200 mg	Oral	Stalevo 75/18.75/200mg	104.87

[7]     Schedule 2

after:

1,954 Losartan Tablet containing losartan potassium 50 mg Oral Cozavan 7.25

insert:

1,954A	Lurasidone	Tablet containing lurasidone hydrochloride 40 mg	Oral	Lurasidone Lupin	46.48
1,954B	Lurasidone	Tablet containing lurasidone hydrochloride 40 mg	Oral	Ardix Lurasidone	46.48
1,954C	Lurasidone	Tablet containing lurasidone hydrochloride 40 mg	Oral	Latuda	46.48
1,954D	Lurasidone	Tablet containing lurasidone hydrochloride 80 mg	Oral	Latuda	92.96
1,954E	Lurasidone	Tablet containing lurasidone hydrochloride 80 mg	Oral	Ardix Lurasidone	92.96
1,954F	Lurasidone	Tablet containing lurasidone hydrochloride 80 mg	Oral	Lurasidone Lupin	92.96

[8]     Schedule 2

after:

2,035 Metformin Tablet (extended release) containing metformin hydrochloride 500 mg Oral Metformin XR 500 APOTEX 3.72

insert:

2.035A Metformin Tablet (prolonged release) containing metformin hydrochloride 500 mg Oral Metformin (Medsurge) 4.01

[9]     Schedule 2

after:

2,096 Methylphenidate Capsule containing methylphenidate hydrochloride 40 mg (modified release) Oral Ritalin LA 38.07

insert:

2,096A Methylphenidate Capsule containing methylphenidate hydrochloride 60 mg (modified release) Oral Ritalin LA 51.01

[10]   Schedule 2

after:

2,367 Nitrazepam Tablet 5 mg Oral Mogadon 1.48

insert:

2,367A	Nitrofurantoin	Capsule 100 mg	Oral	APO-Nitrofurantoin	14.67
2,367B	Nitrofurantoin	Capsule 100 mg	Oral	Macrodantin	14.67
2,367C	Nitrofurantoin	Capsule 50 mg	Oral	Macrodantin	10.46
2,367D	Nitrofurantoin	Capsule 50 mg	Oral	APO-Nitrofurantoin	10.46

[11]   Schedule 2

after:

3,224 Salbutamol Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation) Inhalation by mouth Ventolin CFC-free 3.88

insert:

3,224A	Salbutamol	Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)	Inhalation by Mouth	Zempreon CFC-Free with dose counter	4.49
3,224B	Salbutamol	Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)	Inhalation by Mouth	Ventolin CFC-Free with dose counter	4.49